0001214659-23-008793.txt : 20230623
0001214659-23-008793.hdr.sgml : 20230623
20230623122425
ACCESSION NUMBER: 0001214659-23-008793
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230621
FILED AS OF DATE: 20230623
DATE AS OF CHANGE: 20230623
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cochran John
CENTRAL INDEX KEY: 0001406773
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38599
FILM NUMBER: 231036379
MAIL ADDRESS:
STREET 1: 201 MAIN STREET, SUITE 1900
CITY: FORT WORTH
STATE: TX
ZIP: 76102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aquestive Therapeutics, Inc.
CENTRAL INDEX KEY: 0001398733
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208623253
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 30 TECHNOLOGY DRIVE
CITY: WARREN
STATE: NJ
ZIP: 07059
BUSINESS PHONE: 908-941-1900
MAIL ADDRESS:
STREET 1: 30 TECHNOLOGY DRIVE
CITY: WARREN
STATE: NJ
ZIP: 07059
FORMER COMPANY:
FORMER CONFORMED NAME: MonoSol Rx, Inc.
DATE OF NAME CHANGE: 20070507
4
1
marketforms-61959.xml
PRIMARY DOCUMENT
X0407
4
2023-06-21
0001398733
Aquestive Therapeutics, Inc.
AQST
0001406773
Cochran John
C/O AQUESTIVE THERAPEUTICS, INC.
30 TECHNOLOGY DRIVE
WARREN
NJ
07059
true
false
false
false
0
Common Stock
99486
D
Stock Option (Right to Purchase)
2.02
2023-06-21
4
A
false
25000
0
A
2024-06-21
2033-06-21
Common Stock
25000
25000
D
The shares underlying the options vest as follows: 100% of the underlying shares vest June 21, 2024, subject to Mr. Cochran's continuous service with the Issuer from the grant date through the applicable vesting date.
/s/ Lori Braender, as Attorney-In-Fact
2023-06-23